Documents
Application Sponsors
BLA 225554 | BRISTOL-MYERS SQUIBB | |
Marketing Status
Prescription | 001 |
Prescription | 002 |
Prescription | 003 |
Prescription | 004 |
Application Products
001 | INJECTABLE;INJECTION, SOLUTION | 40MG/4ML | 0 | OPDIVO | NIVOLUMAB |
002 | INJECTABLE;INJECTION, SOLUTION | 100MG/10ML | 0 | OPDIVO | NIVOLUMAB |
003 | INJECTABLE;INJECTION, SOLUTION | 120MG/12ML | 0 | OPDIVO | NIVOLUMAB |
004 | INJECTABLE;INJECTION, SOLUTION | 240MG/124ML | 0 | OPDIVO | NIVOLUMAB |
FDA Submissions
EFFICACY; Efficacy | ORIG | 1 | AP | 2022-03-04 | PRIORITY |
CDER Filings
BRISTOL-MYERS SQUIBB
cder:Array
(
[0] => Array
(
[ApplNo] => 225554
[companyName] => BRISTOL-MYERS SQUIBB
[docInserts] => ["",""]
[products] => [{"drugName":"OPDIVO","activeIngredients":"NIVOLUMAB","strength":"40MG\/4ML","dosageForm":"INJECTABLE;INJECTION, SOLUTION","marketingStatus":"Prescription","te":"None","rld":"No","rs":"No"},{"drugName":"OPDIVO","activeIngredients":"NIVOLUMAB","strength":"100MG\/10ML","dosageForm":"INJECTABLE;INJECTION, SOLUTION","marketingStatus":"Prescription","te":"None","rld":"No","rs":"No"},{"drugName":"OPDIVO","activeIngredients":"NIVOLUMAB","strength":"120MG\/12ML","dosageForm":"INJECTABLE;INJECTION, SOLUTION","marketingStatus":"Prescription","te":"None","rld":"No","rs":"No"},{"drugName":"OPDIVO","activeIngredients":"NIVOLUMAB","strength":"240MG\/124ML","dosageForm":"INJECTABLE;INJECTION, SOLUTION","marketingStatus":"Prescription","te":"None","rld":"No","rs":"No"}]
[labels] => [{"actionDate":"03\/04\/2022","submission":"ORIG-1","supplementCategories":"Approval","inserts":"[{\"name\":\"Label (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/label\\\/2022\\\/225554s112lbl.pdf\"}]","notes":""}]
[originalApprovals] => [{"actionDate":"03\/04\/2022","submission":"ORIG-1","actionType":"Approval","submissionClassification":"","reviewPriority":"N\/A","inserts":"[{\"name\":\"Label (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/label\\\/2022\\\/225554s112lbl.pdf\"}]","notes":">"}]
[supplements] =>
[actionDate] => 2022-03-04
)
)